Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease
$5 million equity investment and initial $1.5 million grant funding [...]
$5 million equity investment and initial $1.5 million grant funding [...]
Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to [...]
First senior executive appointment made following Company launch to oversee [...]
Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to [...]
Investment in new headquarters forms part of ongoing company growth [...]
Ed Rayner joins Sphere Fluidics as new board member to [...]
Collaboration Aims to Provide Researchers Cutting-Edge Tools to Enable Transformational [...]
Access to compound collection enables greater flexibility and efficiencies in [...]
New, larger venue of Convene 133 Houndsditch, central London, offers [...]
License agreement extends access to culture-stable pooled hepatocyte cell models [...]